Michael Simmons is The Spectator's economics editor. Contact him here.
From our UK edition
In the face of the Omicron strain, the UK regulator has approved a drug that its manufacturers, GlaxoSmithKline, claim reduces hopsitalisations and deaths by 79 per cent. The MHRA announced this morning that it had given the NHS approval to start administering the Xevudy antibody drug to everyone over 12. The drug has been sanctioned
From our UK edition
Nicola Sturgeon wants to extend vaccine passports in Scotland, and today her government released a 70-page document purporting to show evidence. The snag? There’s not a shred of evidence to show that her vaccine passports are having any effect. The document, entitled Coronavirus (COVID-19) vaccine certificationww: evidence paper update makes a very bold claim: that Scotland’s
From our UK edition
Nicola Sturgeon is considering extending vaccine passports to Scotland’s cinemas, theatres and pubs. ‘We are also considering whether an expansion of the scheme to cover more settings would be justified and prudent given the current state of the pandemic,’ the First Minister said yesterday: she’ll decide next Tuesday. As she mulls, what data will she
From our UK edition
After the UK medicines regulator yesterday approved Merck’s Covid pill for use on recently infected, vulnerable patients, Pfizer announced its own successful treatment, Paxlovid. Pfizer’s pill was shown to reduce the risk of hospitalisation and death in Covid patients by up to 89 per cent compared with a placebo. The drug has proved so effective
From our UK edition
When Sajid Javid was interviewed at Tory party conference recently, he was asked if he’s going to start firing unvaccinated NHS staff, given that care workers are about to lose their jobs under ‘no jab, no job’ rules. He said he was considering it, which would be quite a move. The unjabbed may make up a small percentage
